| Q38793073 | "Targeting astrocytes in CNS injury and disease: A translational research approach". |
| Q48761037 | Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue. |
| Q41181063 | Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease |
| Q48456362 | Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release |
| Q48543622 | Astroglial cell subtypes in the cerebella of normal adults, elderly adults, and patients with Alzheimer's disease: a histological and immunohistochemical comparison |
| Q44189359 | Behavioural and histopathological analyses of ibuprofen treatment on the effect of aggregated Abeta(1-42) injections in the rat. |
| Q46566282 | Beta-amyloid-induced reactive astrocytes display altered ability to support dendrite and axon growth from mouse cerebral cortical neurons in vitro |
| Q42672221 | Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects |
| Q40992216 | Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders |
| Q48842286 | Correlations between the morphology of diffuse and primitive beta-amyloid (A beta) deposits and the frequency of associated cells in Down's syndrome |
| Q42458427 | Cultured astrocytes express regional heterogeneity of the immunoreactive phenotype under basal conditions and after gamma-IFN induction |
| Q48285810 | Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42). |
| Q90136122 | Does CNS Myelin Inhibit Axon Regeneration? |
| Q48277713 | Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid |
| Q36607337 | Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies |
| Q48591069 | Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus |
| Q39121881 | Nervous system-derived chondroitin sulfate proteoglycans regulate growth cone morphology and inhibit neurite outgrowth: a light, epifluorescence, and electron microscopy study. |
| Q41288053 | Proteoglycans and other repulsive molecules in glial boundaries during development and regeneration of the nervous system |
| Q92719120 | Questions and (some) answers on reactive astrocytes |
| Q98199437 | Regionally encoded functional heterogeneity of astrocytes in health and disease: A perspective |
| Q44419930 | Role of manganese accumulation in increased brain glutamine of the cirrhotic rat. |
| Q52669755 | The Biology of Regeneration Failure and Success After Spinal Cord Injury. |
| Q48880171 | Trk receptor alterations in Alzheimer's disease. |